USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Analysis of the Cardiac Biomarker Diagnostics Market
Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment
30-Sep-2015
North America
Market Research
NF62-01-00-00-00
HC02515-NA-MR_16636
The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.
Key Findings
Competitive Landscape
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
- Nanomix (POCT)
- Critical Diagnostics (Lab-based)
- CardioDx (POCT)
3 Big Predictions
Cardiac Diagnostics Industry Overview
Cardiac Biomarkers Diagnostics Overview
Market Background
Cardiac Diagnostics Overview
Testing Procedure
Factors Influencing Adoptability of Tests
Defining Healthcare Trends in the Future
New Market Opportunities
Solutions Provided by Top Companies
Important Partnerships—Cardiac Biomarker IVD Diagnostics
Emerging Biomarkers for MI and Clinical Strength
LDTs—Role in Cardiac Diagnostics
Other Emerging Biomarkers
Market Drivers
Market Restraints
Market Engineering Measurements
Revenue Forecast
Percent Revenue Breakdown by Segments
Segment Lifecycle Analysis
Market Share
Market Share Analysis
Overall Market Share Analysis
Top Competitors
Market Engineering Measurements
Revenue Forecast
POCT—Segment Share
Segment Share Analysis
Competitive Value Matrix
Top POCT Devices in the US Market
Competitive Product Analysis
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Disease Type
Growth Rate by Cardiac Disease
Product Portfolio
Pricing Trends and Forecast
Segment Share
Segment Share Analysis
Competitive Value Matrix
Cardiac Diagnostics Industry Overview
Partnership Trends—Medical Device Diagnostics
Industry Overview
Industry Overview by Application
New Market Opportunities
Imaging Technology—Role in Patient Continuum
Industry Overview
Cardiac Monitoring by Application
New Market Opportunities
ECG Technology—Role in Patient Continuum
Opportunities—Companion Diagnostics
Digital Health and Diagnostics Inter Convergence Model—Cardiac Diagnostics
Opportunity
3 Big Predictions
Legal Disclaimer
List of Others
Market Engineering Methodology
List of Figures
- 1. Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
- 2. Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
- 3. Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
- 4. Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011–2014
- 5. Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US, 2014
- 6. Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015–2021
- 7. Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015–2021
- 8. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
- 9. Total Cardiac Biomarker Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
- 10. Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
- 11. Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
- 12. POCT Segment: Market Engineering Measurements, US, 2014
- 13. POCT Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
- 14. POCT Segment: Top 10 Products, US, 2014
- 15. Lab-based Tests Segment: Market Engineering Measurements, US, 2014
- 16. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
- 17. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
- 18. Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011–2014
- 19. Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
- 20. Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
- 21. Total Cardiac Diagnostics Industry: ECG, US, 2014
- 22. Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
- 23. Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013–2015
List of Charts
- 1. Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
- 2. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
- 3. Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
- 4. Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
- 5. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
- 6. Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
- 7. Total Cardiac Biomarker Diagnostics Market: Adoptability of Biomarker Tests, US, 2014
- 8. Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
- 9. Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
- 10. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
- 11. Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011–2021
- 12. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
- 13. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
- 14. Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
- 15. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
- 16. POCT Segment: Revenue Forecast, US, 2011–2021
- 17. POCT Segment: Percent Revenue Breakdown, US, 2014
- 18. POCT Segment: Competitive Analysis, US, 2014
- 19. POCT Segment: Product Analysis, US, 2014
- 20. Lab-based Tests Segment: Revenue Forecast, US, 2011–2021
- 21. Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011–2021
- 22. Lab-Based Tests Segment: Growth Rate by Cardiac Disease, US, 2011–2021
- 23. Lab-based Tests Segment: Product Analysis, US, 2014
- 24. Lab-based Tests Segment: Average Price, US, 2009–2021
- 25. Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
- 26. Lab-based Tests Segment: Competitive Analysis, US, 2014
- 27. Total Cardiac Diagnostics Market: Industry Overview, US, 2014
- 28. Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
- 29. Total Cardiac Diagnostics Market: Patient Continuum, US, 2014
- 30. Total Cardiac Monitoring Market: Market Segmentation, US, 2014
- 31. Total Cardiac Monitoring Industry: Patient Continuum, US, 2014
- 32. Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013–2015
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
07 Oct 2026 | Global | Technology Research
Growth Opportunities in Image-Guided Cancer Ablation Systems
Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.